Tag: lymphoma

In recent years, innovative cancer drugs that target specific molecular drivers of the disease have been embraced as the treatment ...

(MIAMI, FL, FEB. 21, 2023) – To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or ...

Two new grants from The Leukemia & Lymphoma Society (LLS) will support Weill Cornell Medicine’s pathbreaking research on the origins ...

Intentional modifications to diet are being investigated as a strategy to reduce chronic cancer-related fatigue, according to new data published ...

“The current analysis provides updated results for these lymphoma patients with extended follow-up.”  Credit: 2023 Gordon et al. “The current ...

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are ...

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are ...

“Taken together, these findings provide a strong rationale for potently and selectively targeting of CD74 in patients with B-NHL .”  ...

“Here, we describe results using cladribine based combination epigenetic and immunotherapy in MCL .” Credit: 2022 LeBlanc et al. “Here, ...

NEW ORLEANS - A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in ...

NEW YORK, NY--The incidence of a rare cancer, anaplastic large-cell lymphoma (ALCL), has surged in recent years, possibly because of the growing ...

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, ...

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Marginal Zone Lymphoma. A ...

(Memphis, Tenn.—September 8, 2022) Why did my child get cancer? Clinicians have longed for a way to help answer this ...

In the war against cancer, one of the most critical battles is waged on a cellular level as T cells ...

In the war against cancer, one of the most critical battles is waged on a cellular level as T cells ...

Researchers at Stanford University have developed “decoy receptor” molecules that inhibit the growth of both multiple myeloma (MM) and diffuse ...

Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but ...

ABSTRACT LBA7502 Combination chemoimmunotherapy with the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for ...

DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively ...